This content is machine translated Chronic inflammatory dermatoses Atopic dermatitis rarely comes alone – an update on important comorbidities. According to current understanding, atopic dermatitis is a T cell-mediated chronic inflammatory dermatosis, whereby the systemic inflammation may also affect extracutaneous body compartments. In addition to the comorbidity risks described…
View Post 5 min This content is machine translated Relapsed/refractory multiple myeloma The BCMA molecule as a beacon of hope The prognosis in relapsed and refractory multiple myeloma (RRMM) remains grim. Now, at the annual meeting of the American Society of Hematology (ASH), data have been presented that raise faint…
View Post 7 min This content is machine translated Triple-negative stage I-III breast carcinoma Attack on an untouchable While targeted therapies are on the rise, there are still tumors that cannot (yet) benefit from this development. One such is triple-negative breast carcinoma. But even here, far from targeted…
View Post 4 min This content is machine translated Chronic obstructive pulmonary disease (COPD) Reduce exacerbation rate and improve quality of life Assessment of symptoms and exacerbation risks is central to effective drug therapy. The ABCD risk classification serves as a basis for this. Here, the indication for therapy is based on…
View Post 5 min This content is machine translated Psoriasis therapy in pediatric patients. IL17A inhibitors effective and safe in childhood and adolescent psoriasis patients Children and adolescents with psoriasis are often significantly limited in their quality of life. There is a need for new treatment options for this patient population, especially for cases with…
View Post 4 min This content is machine translated GLP-1 receptor agonists (GLP-1-RA) Type 2 diabetics benefit from dulaglutide in several ways The ADA/EASD guidelines recommend individualized therapy choices for type 2 diabetics. GLP-1 receptor agonists not only improve glycemic control, but also support weight loss, reduce the risk of cardiovascular disease,…
View Post 4 min This content is machine translated Study Overview What’s new in the world of cardiology? Scientific research is constantly being pursued, enabling advances to be made time and again in the therapeutic management of cardiological diseases. The most interesting study results around pericarditis, chronic coronary…
View Post 5 min This content is machine translated Corona pandemic Diabetes patients with COVID-19: current expert assessment. Poorly controlled diabetes is a risk factor for severe COVID-19 progression. Therefore, especially during the corona pandemic, the best possible blood glucose control is crucial. However, it has been shown…
View Post 5 min This content is machine translated Non-resectable gastric carcinoma Immunotherapy on the rise The prognosis of advanced gastric carcinoma remains extremely unfavorable. Accordingly, new treatment approaches are urgently needed. Current evidence suggests that checkpoint inhibitor therapy may become more important in the near…
View Post 16 min This content is machine translated Type 2 diabetes The cardiovascular diabetic patient – an interdisciplinary challenge A patient with type 2 diabetes is 2-3 times more likely to have a myocardial infarction or stroke than people without diabetes. Cardiovascular disease accounts for up to 50% of… CME-Test
View Post 4 min This content is machine translated COPD therapy The less eosinophilic the COPDer, the more unnecessary the ICS “Treatable traits” is the new magic term in the treatment of COPD, and the current guidelines are modeled after it. With regard to the structure of therapy, the focus should…
